RAPID ELIMINATION BY GLOMERULAR FILTRATION OF FREE PROSTATE SPECIFIC ANTIGEN AND HUMAN KALLIKREIN 2 AFTER RENAL TRANSPLANTATION
- 1 April 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (4) , 1432-1435
- https://doi.org/10.1097/01.ju.0000118580.19344.68
Abstract
Purpose: The low molecular mass and short half-life of free (f) prostate specific antigen (PSA) implies elimination from blood by glomerular filtration. In addition, patients with terminal renal failure have increased fPSA in serum but there have been sparse data reported on the rates and pathways of elimination of PSA complexes and human kallikrein 2 (hK2). We studied glomerular filtration dependent elimination of fPSA and hK2 in patients with renal insufficiency undergoing successful renal transplantation. Materials and Methods: We studied 14 patients with immediate onset of renal function after renal transplantation. Blood samples were obtained before and at regular intervals up to 160 hours after transplanted kidney reperfusion. Measurements of fPSA, total PSA and hK2 were performed with immunofluorometric assays and complexed PSA was determined by a chemiluminiscence assay. Glomerular filtration rates were monitored by analyzing serum creatinine and cystatin C. NONMEM, a multivariate pharmacokinetic approach, was used to determine the elimination rates of fPSA and hK2 after renal transplantation. Results: Serum fPSA and hK2 but not PSA complexes, decreased rapidly after renal transplantation. Significant reductions in fPSA and hK2 were observed after only 16 and 8 hours, respectively. fPSA and hK2 showed similar elimination patterns, decreasing to 42% and 44% of their original levels compared to cystatin C, which was at 44% after 160 hours. The median half-lives of fPSA and hK2 were 17.4 and 11.5 hours, respectively. Conclusions: These results verify the hypothesis that fPSA and hK2 are eliminated from the blood circulation by glomerular filtration and severe renal failure influences the levels of the 2 proteins in serum.Keywords
This publication has 14 references indexed in Scilit:
- Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatmentNephrology Dialysis Transplantation, 2003
- DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUMJournal of Urology, 2000
- Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy—a critical assessmentUrology, 1999
- In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mLUrology, 1998
- SERUM LEVELS OF TOTAL AND FREE PROSTATE SPECIFIC ANTIGEN IN MEN ON HEMODIALYSISJournal of Urology, 1998
- Rapid Exponential Elimination of Free Prostate-Specific Antigen Contrasts the Slow, Capacity-Limited Elimination of PSA Complexed to Alpha1-Antichymotrypsin From SerumUrology, 1998
- Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum β2-microglobulin/cystatin C-ratioScandinavian Journal of Clinical and Laboratory Investigation, 1997
- Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomyUrology, 1996
- Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.Journal of Clinical Investigation, 1993
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991